Editorial Comment

J Urol. 2018 Sep;200(3):581. doi: 10.1016/j.juro.2018.03.160. Epub 2018 Jun 11.
No abstract available

Publication types

  • Comment

MeSH terms

  • Androgen Antagonists
  • Humans
  • Liver Diseases*
  • Male
  • Prostatic Neoplasms*

Substances

  • Androgen Antagonists